Lab

During routine reviews of batch production records (BPRs) in preparation for an upcoming FDA inspection, a Quality Assurance (QA) manager noticed discrepancies related to process parameters documented versus those observed during manufacturing. Specifically, the documentation showed that a critical mixing speed parameter for a tablet compression process was altered without formal approval. Symptoms of this deviation became apparent through:

• Increased observation of out-of-specification (OOS) results for product consistency.
• Unusual fluctuations in the physical characteristics of the tablets, such as hardness and friability.
• Staff reports indicating confusion over process guidance due to undocumented changes made to the machinery settings.
• Inconsistencies in the material flow, suggesting that a fundamental shift in manufacturing parameters was not communicated effectively.

The culmination of these symptoms pointed towards a potential major compliance issue, which was exacerbated by the impending inspection.

Likely Causes

Analyzing the situation, it became crucial to categorize potential root causes to facilitate a thorough investigation. The following framework based on the “5 Ms” (Materials, Method, Machine, Man, Measurement) helped in identifying contributing factors:

Category	Potential Causes
Materials	Variation in excipients which may require adjustment of processing parameters.
Method	Lack of clear procedures documenting approved settings for equipment.
Machine	Calibration drift of the mixing equipment affecting operational parameters.
Man	Insufficient training for operators regarding adherence to validated settings.
Measurement	Deficiencies in monitoring systems that do not capture real-time deviations.

Understanding these categories allowed the team to tailor their investigation and identify where improvements were needed to prevent similar incidents in the future.

Immediate Containment Actions (first 60 minutes)

Upon discovery of the unapproved parameter change, immediate containment actions were crucial to limit the potential impact on current production and ensure compliance with regulatory expectations:

1. Stop All Ongoing Production: Communication was made to halt all batch production utilizing the modified parameter to prevent further issues.
2. Assess Batch Impact: A preliminary assessment was conducted on all affected batches to determine if an extension of OOS results occurred, which required further bioburden testing.
3. Initiate Deviation Report: A formal deviation report was generated to document the incident promptly, detailing the unapproved change and initial findings.
4. Notify Regulatory Affairs: The Regulatory Affairs department was informed immediately, and as part of protocol, they began compiling necessary information for potential communication with FDA if needed.
5. Document Everything: Detailed records were maintained of all actions taken, including timelines, involved personnel, and decision points to ensure traceability for any future inspections.

This swift action provided a framework that would not only assist in reducing the size of the problem but also set the stage for a comprehensive investigation.

Investigation Workflow (data to collect + how to interpret)

The investigation into the unapproved process parameter change required a systematic and comprehensive approach to gather relevant data. The following steps were executed:

1. Data Collection:
   • Batch Production Records (BPRs) related to the affected product, including documentation of any deviations.
   • Process parameter logs from the manufacturing equipment to establish a timeline of changes.
   • Staff training records to determine if operators were adequately informed about the process parameters.
   • Calibration records of the mixing equipment to ascertain if mechanical failures contributed to the issue.
   • Previous inspection reports to analyze trends in compliance or recurring issues around process parameters.
2. Data Interpretation: Evaluating the collected data helped discern patterns or changes that coincided with parameter alterations. Rapid reviews involved cross-referencing logs and BPRs with operator interviews to identify communication gaps.

This structured approach not only bolstered the investigation process but also established a reiterative mechanism to decide on future action points.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

Utilizing root cause analysis tools is vital for identifying systemic failures. Each method has strengths for various situations:

• 5-Why Analysis: This is a straightforward tool for identifying the root cause of a problem by repeatedly asking “why” until the fundamental cause is revealed. This method is best for simpler issues where a clear chain of cause and effect is present.
• Fishbone Diagram (Ishikawa): Ideal for more complex problems, this diagram organizes potential causes into categories (like Man, Machine, Method, etc.). It is particularly useful when numerous factors may contribute to a deviation, allowing teams to visualize relationships among them.
• Fault Tree Analysis: A top-down approach that evaluates the different paths that can lead to a system failure. This method is useful for analyzing processes with multiple interacting components and can identify failure points that may not be immediately evident.

For this case, the Fishbone diagram was selected due to the multifaceted nature of the deviation, as multiple concurrent issues needed examination.

CAPA Strategy (correction, corrective action, preventive action)

The Corrective and Preventive Action (CAPA) strategy included three specific components for addressing the unapproved process parameter change:

1. Correction: Immediately revert to the last validated process parameters in all ongoing and future batches. Additionally, all processed batches were quarantined pending a full risk assessment.
2. Corrective Action: Standard Operating Procedures (SOPs) were revised to incorporate checks that would preempt alteration of approved process parameters without proper documentation. This includes incorporating checks and balances for all process changes.
3. Preventive Action: Implement ongoing technical training for operators and personnel involved in the manufacturing process to reinforce the importance of adhering to validated parameters. Regular mock inspections and drills were introduced to foster a culture of compliance and readiness.

These actions created a structured response to the deviation and enhanced overall operational integrity.

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

To effectively monitor the impact of implemented CAPAs, a control strategy was established focusing on Statistical Process Control (SPC) along with other monitoring components:

1. SPC Implementation: The statistical monitoring of process parameters was established to detect variations promptly. Control charts were developed for critical parameters such as mixing time and speed, with predefined limits clearly communicated across the team.
2. Regular Sampling: Introduce regular sampling of both in-process and final containers of the product to ensure compliance with established parameters and specifications. A bi-monthly review of these samples was instituted.
3. Real-Time Alarms: Set up alarm systems on mixing equipment that alerted personnel if any parameters strayed outside preset limits, ensuring immediate investigation was possible.
4. Verification of Compliance: A monthly verification process of all reported parameters and outputs was introduced to ensure compliance with revised SOPs. This also involved routine audits that cross-verify logs against actual performance data.

This comprehensive control strategy ensured that the manufacturing processes remained within compliance bounds and prepared for any potential inspections.

Related Reads

• Managing Training and Documentation Deviations in Pharma
• Managing Cleaning and Cross-Contamination Deviations in Pharma Manufacturing

Validation / Re-qualification / Change Control Impact (when needed)

Given the nature of the deviation, the impact on validation, re-qualification, and change control processes was significant:

• Validation: All product lines affected by the parameter change required re-validation to ensure that any modifications had not introduced unforeseen variables that could affect product quality.
• Re-qualification: Equipment involved in the process was re-qualified to ensure its performance was within required standards, considering the recent parameter adjustments.
• Change Control: A stricter change control process was implemented. Any future adjustments to process parameters would necessitate cross-departmental sign-off and a formalized review process to prevent unauthorized alterations.

Documentation of all changes and validations were kept thoroughly to ensure adherence to GMP and for future inspection readiness.

Inspection Readiness: What Evidence to Show

When preparing for future inspections post-deviation incident, readily available evidence helps demonstrate a robust response to regulatory expectations. Key documents included:

• All deviation reports detailing the incident, findings, actions taken, and timelines.
• Revised SOPs that encompass the new changes and controls put into place.
• Training records showing that all personnel were retrained in updated procedures.
• SPC charts and monitoring logs evidencing process parameter control and compliance.
• Batch records reflecting any quarantined or rejected products due to the unapproved changes.

Additionally, preparedness for inquiries about corrective actions taken, monitoring strategies implemented, and documented lessons learned will be crucial during any regulatory review.

FAQs

What is an unapproved process parameter change?

An unapproved process parameter change refers to any alteration made to documented manufacturing procedures that has not received formal approval through established change control protocols.

What steps should be taken when a deviation is identified?

Immediate steps include halting production, assessing the impact on existing batches, creating a deviation report, and informing relevant departments before initiating an investigation.

How can we prevent unapproved changes in the future?

To prevent such changes, implement rigorous change control procedures, continuous staff training, effective documentation practices, and robust monitoring of processes.

What are the consequences of failing to follow approved SOPs?

Failing to follow approved SOPs can lead to product quality issues, regulatory non-compliance, and potential recalls, along with adverse findings during inspections.

How often should equipment be calibrated?

Equipment calibration frequency should align with manufacturer specifications, regulatory requirements, and based on the criticality of the equipment’s role in manufacturing.

What is the importance of data integrity in manufacturing?

Data integrity is fundamental in ensuring that all records are accurate, consistent, and reliable, which in turn supports compliance with GMP and quality assurance standards.

What constitutes a robust CAPA plan?

A robust CAPA plan should address immediate corrections, long-term corrective actions, and strategies to prevent recurrence, ensuring comprehensive documentation and follow-through.

When should a new validation study be initiated?

A new validation study should be initiated when significant changes are made to processes, equipment, or facilities that may affect the quality of the product.

What role does training play in preventing deviations?

Training ensures that all personnel are informed about current procedures and the importance of compliance, significantly reducing the risk of unapproved modifications.

How does SPC contribute to compliance?

SPC helps monitor process variability in real-time, allowing for early detection of deviations from approved parameters and enabling proactive decision-making to ensure compliance.

What records are essential during an FDA inspection?

Essential records during an FDA inspection include BPRs, deviation reports, training logs, SOPs, calibration logs, and evidence of corrective action implementation.

What is an effective way to conduct an investigation?

An effective investigation should follow a structured workflow that includes data collection, team interviews, root cause analysis, and documentation of all findings and actions taken.

Conclusion

In summary, the case of the unapproved process parameter change reveals significant insights into operational protocols within pharmaceutical manufacturing. By adhering to structured investigations and leveraging effective CAPA strategies, companies can not only address immediate compliance challenges but also foster a culture of continuous improvement. Understanding and documenting every aspect of the investigation is key to ensuring ongoing compliance and readiness for regulatory scrutiny.